Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08VGM
|
||||
Former ID |
DNC002537
|
||||
Drug Name |
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H22IN3O6S
|
||||
Canonical SMILES |
C1=CC=C(C(=C1)CSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)I
|
||||
InChI |
1S/C17H22IN3O6S/c18-11-4-2-1-3-10(11)8-28-9-13(16(25)20-7-15(23)24)21-14(22)6-5-12(19)17(26)27/h1-4,12-13H,5-9,19H2,(H,20,25)(H,21,22)(H,23,24)(H,26,27)/t12-,13-/m0/s1
|
||||
InChIKey |
QFYJAEOZTBVJQM-STQMWFEESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Inhibitor | [551393] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.